CN¥16.86
0.65%
Hong Kong, Nov 04, 03:00 pm HKT. Closed.
ISIN
CNE1000012B3
Symbol
2607

Shanghai Pharmaceuticals Holding Stock price

CN¥16.86
+0.64 3.95% 1M
-0.23 1.35% 6M
-1.00 5.60% YTD
-0.96 5.39% 1Y
-1.24 6.85% 3Y
-1.29 7.11% 5Y
-3.65 17.80% 10Y
+11.48 213.19% 20Y
Hong Kong, Closing price Wed, Nov 04 2026
-0.11 0.65%
Compare with Peer Group
ISIN
CNE1000012B3
Symbol
2607

AI Insights on Shanghai Pharmaceuticals Holding Insights AI Insights on Shanghai Pharmaceuticals Holding

How does the company make money?
Who are the company’s main competitors?
What are the key opportunities and risks?

Is Shanghai Pharmaceuticals Holding a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 9,093 stocks worldwide.

Key metrics

Basic
Market capitalization
CN¥55.4b
Enterprise Value
CN¥71.4b
Net debt
-
Cash
-
Shares outstanding
-
Valuation
P/E
12.2
P/S | estimate
0.2 | 0.2
EV/Sales | estimate
0.2 | 0.2
EV/FCF | ex SBC
10.4 | -
P/B
0.7
Dividends
DPS
CN¥0.52
Yield 1Y | 5Y
3.1% | 2.7%
Growth 1Y | 5Y
16.1% | 1.7%
Payout 1Y | 3Y
29.2% | 40.9%
Increased
1 Year
Financials
Revenue | estimate
CN¥291.5b | CN¥299.7b
EBITDA
-
EBIT
CN¥9.2b
Net Income
CN¥5.2b
Free Cash Flow | ex SBC
CN¥6.9b | -
Growth
Revenue | estimate
3.8% | 5.7%
EBITDA
-
EBIT
23.4%
Net Income
-8.5%
Free Cash Flow
114.2%
Margin
Gross
10.5%
EBITDA
-
EBIT
3.2%
Net
1.8%
Free Cash Flow | ex SBC
2.4% | -
Financial Health
Equity Ratio
32.6%
Return on Equity
7.5%
ROCE
9.2%
ROIC
5.5%
Debt/Equity
-
More
EPS
CN¥1.4
FCF per Share
CN¥1.9
Short interest
-
Employees
50k
Rev per Employee
CN¥5.7m

Shanghai Pharmaceuticals Holding Stock Analysis

Unlock Scores for Free

Analyst Opinions

11 Analysts have issued a Shanghai Pharmaceuticals Holding forecast:

7x Buy
64%
3x Hold
27%
1x Sell
9%

Analyst Opinions

11 Analysts have issued a Shanghai Pharmaceuticals Holding forecast:

Buy
64%
Hold
27%
Sell
9%

Shanghai Pharmaceuticals Holding Events

Past Events
OCT
29
Q3 2026 Earnings Call
6 days ago

Financial data from Shanghai Pharmaceuticals Holding

Sep '26
+/-
%
291,471 291,471
4% 4%
100%
- Direct Costs 260,903 260,903
4% 4%
90%
30,568 30,568
5% 5%
10%
- Selling and Administrative Expenses 19,267 19,267
3% 3%
7%
- Research and Development Expense 2,340 2,340
2% 2%
1%
- -
-
-
- Depreciation and Amortization - -
-
-
EBIT (Operating Income) EBIT 9,215 9,215
23% 23%
3%
Net Profit 5,163 5,163
9% 9%
2%

In millions CNY.

Don't miss a Thing! We will send you all news about Shanghai Pharmaceuticals Holding directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

Shanghai Pharmaceuticals Holding Co Ltd is a CN-based company operating in Health Care Providers & Services industry. The company is headquartered in Shanghai, Shanghai and currently employs 49,402 full-time employees.

Head office China
Employees 49,608
Website www.sphchina.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today